Sporothrix brasiliensis is the predominant etiological agent of sporotrichosis in Brazil and has been progressively expanding its geographic distribution to other countries in South America. The human patients infected with S. brasiliensis usually respond favorably to antifungal therapy. However, therapeutic failure ma...
Vanessa Brito de Souza Rabello, Marcus de Melo Teixeira, Fernando Almeida-Silva et al.· Mycopathologia· 0 citations
Background/Objectives: Dermatophytosis is among the most prevalent fungal infections worldwide, and the emergence of antifungal resistance highlights the need for novel the-rapeutic strategies. Organoselenium compounds have demonstrated promising antifungal activity against several pathogenic fungi, although their acti...
Beatriz de Souza Cardoso, M. D. dos Santos, M. Trápaga et al.· Antibiotics· 0 citations
Two cases of severe multifocal cutaneous sporotrichosis caused by S. brasiliensis in PLHIV from a hyperendemic region in southern Rio Grande do Sul, Brazil, highlight that extensive tissue destruction and permanent deformities, resembling that from other systemic mycoses, can occur in PLHIV.
V. Poester, Bianca dos Santos Blan, R. Basso et al.· Pathogens· 0 citations
Sporothrix brasiliensis is driving a major zoonotic epidemic in Brazil, predominantly via cat-to-human transmission. In the late 1990s major outbreaks were reported in Rio de Janeiro (RJ) and Rio Grande do Sul (RS), the southernmost state. We characterized the antifungal susceptibility and genetic diversity of 450 S. b...
M. Trápaga, B. Spruijtenburg, Jéssica Estefânia Dávila Hidalgo et al.· Mycopathologia· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
